Eli Lilly and Company (BVMF:LILY34)
Brazil · Delayed Price · Currency is BRL | Market Cap | 4.61T +10.4% |
| Revenue (ttm) | 376.90B +47.4% |
| Net Income | 131.86B +127.6% |
| EPS | 146.86 +129.1% |
| Shares Out | n/a |
| PE Ratio | 34.93 |
| Forward PE | 27.37 |
| Dividend | 0.73 (0.43%) |
| Ex-Dividend Date | May 14, 2026 |
| Volume | 5,594 |
| Average Volume | 21,451 |
| Open | 171.80 |
| Previous Close | 170.79 |
| Day's Range | 167.99 - 174.34 |
| 52-Week Range | 113.00 - 208.36 |
| Beta | 0.48 |
| RSI | 61.45 |
| Earnings Date | Apr 30, 2026 |
About Eli Lilly and Company
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provi... [Read more]
Financial Performance
In 2025, Eli Lilly and Company's revenue was $65.18 billion, an increase of 44.70% compared to the previous year's $45.04 billion. Earnings were $20.64 billion, an increase of 94.90%.
Financial numbers in USD Financial StatementsNews
Eli Lilly accuses church bishops, businessmen of fraud in Trulicity drug rebate scheme
Eli Lilly has disclosed in a civil lawsuit filed in federal court on Tuesday that a rebate fraud scheme cost it more than $200 million. The company alleges several bishops and a leader of the Church o...
Eli Lilly (LLY) Acquires Engage Biologics for $202 Million
The pharma giant is strengthening its drug pipeline.
Eli Lilly acquires Engage Biologics for up to $202M in cash
Engage Biologics announced that it has been acquired by Eli Lilly (LLY). Engage is developing the Tethosome platform, a non-viral DNA delivery system “designed to overcome key limitations in DNA…
President Trump Bought Eli Lilly Stock (LLY) as Government Approved Weight-Loss Pill
The purchase has raised ethical questions in Washington, D.C.
PFE, NVO, LLY: Pharma Stocks Drop as TrumpRx Set for ‘Dramatic Expansion’
Shares in drugmakers Pfizer ($PFE), Eli Lilly ($LLY), and Novo Nordisk ($NVO) edged lower on Monday afternoon after CNBC’s Megan Cassella revealed that President Donald Trump is set to announce…
Eli Lilly (LLY) Dealt Blow as U.S. Supreme Court Refuses to Hear Whistleblower Law Challenge
The pharma company’s arguments have failed to sway the courts.
Lilly to participate in Bernstein's 42nd Annual Strategic Decisions Conference
INDIANAPOLIS, May 18, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in Bernstein's 42nd Annual Strategic Decisions Conference on May 28, 2026. Daniel M. Skovronsky, M.D.
Eli Lilly appeal to Supreme Court rejected
A writ of certiorari was denied by the U.S. Supreme Court in the case of Eli Lilly (LLY) v. Streck, Ronald J., meaning that the Court has declined to hear…
US Supreme Court turns away Eli Lilly's challenge to whistleblower law
The U.S. Supreme Court declined on Monday to hear a challenge by drugmaker Eli Lilly to a Civil War-era whistleblower law that has recovered billions of dollars by allowing private individuals to br...
Eli Lilly (LLY) Is the Face of the Obesity Drug Boom. Has the Market Already Priced It In?
Eli Lilly ($LLY) has become the face of the global obesity drug boom, powered by its GLP-1 (glucagon-like peptide-1) based tirzepatide franchises Mounjaro and Zepbound. This has redefined its earnings...
As millions flock to GLP-1s, doctors warn of a rise in frailty caused by rapid muscle wasting
Losing muscle, as well as fat, is an unexpected downside of the popular drugs that isn't broadly discussed or immediately apparent.
Lilly, Caitlin Clark Foundation, and Musco Lighting open three community sports courts in Indianapolis, expanding year-round access for youth
Lilly to provide park and court to the City of Indianapolis as part of its 150th anniversary celebration INDIANAPOLIS, May 16, 2026 /PRNewswire/ -- The Caitlin Clark Foundation, in partnership with El...
Jim Cramer Sees a ‘Bull Market’ for Eli Lilly Stock (LLY)
The pharma company has a best-selling weight-loss pill on its hands.
Eli Lilly, Unicef announce collaboration
Eli Lilly (LLY) and Company and UNICEF USA announced a collaboration aiming to improve non-communicable disease prevention and care for children, reaching over 30 million young people and caregivers a...
Lilly and UNICEF collaborate to give millions of children a healthier start
Six-year initiative to improve non-communicable disease prevention and care for children in low- and middle-income countries NEW YORK and INDIANAPOLIS, May 14, 2026 /PRNewswire/ -- Eli Lilly and Compa...
Charts to Watch: SPX All-Time High, CIFR & LLY Breakouts
@CharlesSchwab's Kevin Horner breaks down key market charts as the S&P 500 (SPX) taps new record highs, backed by investors defending the 10-day SMA. In stock movers, he highlights notable technical s...
Eli Lilly launches Alzheimer's drug Donanemab in India
U.S.-based drugmaker Eli Lilly on Wednesday launched its Alzheimer's drug Lormalzi, also known as Donanemab, in India.
Eli Lilly discloses results on Foundayo and lower-dose Zepbound
The company states: “Eli Lilly (LLY) announced detailed results from two late-phase trials showing that people with obesity maintained their weight loss long term with either Foundayo or lower-dose Ze...
Patients don't regain much weight switching from injections to Lilly's weight-loss pill, study finds
Eli Lilly said on Tuesday that patients in a late-stage trial who had been taking an injectable GLP-1 medication for over a year did not regain significant weight after switching to its new weight-l...
Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials
In ATTAIN-MAINTAIN, participants who transitioned from a maximum tolerated dose (MTD) of Wegovy (semaglutide) to Foundayo maintained all but 0.9 kg of their previously achieved weight loss on average ...
In honor of its 150th anniversary, Eli Lilly and Company commits to support community organizations aiming to provide 500,000 meals and cold storage for 150 food pantries
Through charitable support of HATCH, United Way Worldwide, United Way of Central Indiana and the Pacers Foundation, the initiative supports efforts to expand access to protein-rich food across communi...
Exclusive: Lilly halts India obesity awareness campaign after regulatory scrutiny, seeks rules clarity
Eli Lilly paused its obesity awareness campaign in India after the nation's drugs regulator warned the company it could violate rules against advertising prescription medicines to consumers even indi...
NYSE Content Update: Eli Lilly to Celebrate 150 Years of Scientific Innovation
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 11, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NY...
AI, Obesity Drugs, and Diagnostics Fuel Healthcare Growth
Healthcare is regaining momentum as innovation—especially AI‑driven drug discovery—creates new growth opportunities, according to Shivani Vohra. She points to obesity treatments from Eli Lilly (LLY) a...